Found: 78
Select item for more details and to access through your institution.
Spatial dynamics of CD39<sup>+</sup>CD8<sup>+</sup> exhausted T cell reveal tertiary lymphoid structures-mediated response to PD-1 blockade in esophageal cancer.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-53262-w
- By:
- Publication type:
- Article
Long‐term effects of crizotinib in ALK‐positive tumors (excluding NSCLC): A phase 1b open‐label study.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 5, p. 607, doi. 10.1002/ajh.25043
- By:
- Publication type:
- Article
Sidedness-Dependent Prognostic Impact of Gene Alterations in Metastatic Colorectal Cancer in the Nationwide Cancer Genome Screening Project in Japan (SCRUM-Japan GI-SCREEN).
- Published in:
- Cancers, 2023, v. 15, n. 21, p. 5172, doi. 10.3390/cancers15215172
- By:
- Publication type:
- Article
An Investigator-Initiated Phase 2 Study of Nivolumab Plus Low-Dose Ipilimumab as First-Line Therapy for Microsatellite Instability—High Advanced Gastric or Esophagogastric Junction Cancer (NO LIMIT, WJOG13320G/CA209-7W7).
- Published in:
- Cancers, 2021, v. 13, n. 4, p. 805, doi. 10.3390/cancers13040805
- By:
- Publication type:
- Article
Characterization of a newly established human gallbladder carcinoma cell line.
- Published in:
- 1994
- By:
- Publication type:
- Letter
Growth modulation of human tumor cells by a growth-inhibiting activity derived from tumorigenic V79 chinese hamster cells.
- Published in:
- In Vitro Cellular & Developmental Biology Animal, 1993, v. 29, n. 4, p. 332, doi. 10.1007/BF02633962
- By:
- Publication type:
- Article
A 10‐Item Frailty Index Based on a Comprehensive Geriatric Assessment (FI‐CGA‐10) in Older Adults with Cancer: Development and Construct Validation.
- Published in:
- Oncologist, 2021, v. 26, n. 10, p. e1751, doi. 10.1002/onco.13894
- By:
- Publication type:
- Article
Propensity Score Analysis of Regorafenib Versus Trifluridine/Tipiracil in Patients with Metastatic Colorectal Cancer Refractory to Standard Chemotherapy (REGOTAS): A Japanese Society for Cancer of the Colon and Rectum Multicenter Observational Study.
- Published in:
- Oncologist, 2018, v. 23, n. 1, p. 7, doi. 10.1634/theoncologist.2017-0275
- By:
- Publication type:
- Article
Aromatase inhibitors with or without luteinizing hormone-releasing hormone agonist for metastatic male breast cancer: report of four cases and review of the literature.
- Published in:
- Breast Cancer (13406868), 2016, v. 23, n. 6, p. 945, doi. 10.1007/s12282-016-0679-2
- By:
- Publication type:
- Article
Team approach to providing the multidisciplinary medical treatment derived by the patients and their family.
- Published in:
- Breast Cancer (13406868), 2005, v. 12, n. 1, p. 21, doi. 10.2325/jbcs.12.21
- By:
- Publication type:
- Article
Mutational spectrum of TP53 gene correlates with nivolumab treatment efficacy in advanced gastric cancer (TP53MUT study).
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 6, p. 1032, doi. 10.1038/s41416-023-02378-9
- By:
- Publication type:
- Article
OX40 and LAG3 are associated with better prognosis in advanced gastric cancer patients treated with anti-programmed death-1 antibody.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Phase 2 Study of Modified Irinotecan and Bolus 5-Fluorouracil/ l-Leucovorin in Japanese Metastatic Colorectal Cancer Patients.
- Published in:
- Advances in Therapy, 2012, v. 29, n. 3, p. 287, doi. 10.1007/s12325-012-0002-3
- By:
- Publication type:
- Article
Phase 2 study of modified irinotecan and bolus 5-fluorouracil/l-leucovorin in Japanese metastatic colorectal cancer patients.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Primary tumor location as a predictor of survival in patients with RAS wild-type colorectal cancer who receive molecularly targeted drugs as first-line therapy: a multicenter real-world observational study by the Japanese Society for Cancer of the Colon and Rectum
- Published in:
- International Journal of Clinical Oncology, 2022, v. 27, n. 9, p. 1450, doi. 10.1007/s10147-022-02208-7
- By:
- Publication type:
- Article
Treatment strategies for neuroendocrine carcinoma of the upper digestive tract.
- Published in:
- International Journal of Clinical Oncology, 2020, v. 25, n. 5, p. 842, doi. 10.1007/s10147-020-01631-y
- By:
- Publication type:
- Article
Prognostic scores for evaluating the survival benefit of regorafenib or trifluridine/tipiracil in patients with metastatic colorectal cancer: an exploratory analysis of the REGOTAS study.
- Published in:
- International Journal of Clinical Oncology, 2020, v. 25, n. 4, p. 614, doi. 10.1007/s10147-019-01600-0
- By:
- Publication type:
- Article
Favorable control of advanced colon adenocarcinoma with severe bone marrow metastasis: A case report.
- Published in:
- 2016
- By:
- Publication type:
- Case Study
Bevacizumab in combination with irinotecan, 5-fluorouracil, and leucovorin (FOLFIRI) in patients with metastatic colorectal cancer who were previously treated with oxaliplatin-containing regimens: a multicenter observational cohort study (TCTG 2nd-BV study)
- Published in:
- Medical Oncology, 2012, v. 29, n. 4, p. 2842, doi. 10.1007/s12032-011-0151-2
- By:
- Publication type:
- Article
Implementation of institutional antiemetic guidelines for low emetic risk chemotherapy with docetaxel: a clinical and cost evaluation.
- Published in:
- Supportive Care in Cancer, 2012, v. 20, n. 8, p. 1805, doi. 10.1007/s00520-011-1278-6
- By:
- Publication type:
- Article
Phase Ib study of FOLFOXIRI plus ramucirumab as first-line treatment for patients with metastatic colorectal cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Multicenter phase II study of SOX plus trastuzumab for patients with HER2<sup>+</sup> metastatic or recurrent gastric cancer: KSCC/HGCSG/CCOG/PerSeUS 1501B.
- Published in:
- 2020
- By:
- Publication type:
- journal article
A phase II study of NK012, a polymeric micelle formulation of SN-38, in unresectable, metastatic or recurrent colorectal cancer patients.
- Published in:
- 2018
- By:
- Publication type:
- journal article
The risk factors for oxaliplatin-induced peripheral sensory neuropathy and thrombocytopenia in advanced gastric cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Suggestion of added value by bevacizumab to chemotherapy in patients with unresectable or recurrent small bowel cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
LJM716 in Japanese patients with head and neck squamous cell carcinoma or HER2-overexpressing breast or gastric cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Safety and tolerability of the olaparib tablet formulation in Japanese patients with advanced solid tumours.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Safety and tolerability of AZD5363 in Japanese patients with advanced solid tumors.
- Published in:
- 2016
- By:
- Publication type:
- journal article
A phase II study of S-1, oxaliplatin, oral leucovorin, and bevacizumab combination therapy (SOLA) in patients with unresectable metastatic colorectal cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 76, n. 3, p. 547, doi. 10.1007/s00280-015-2825-5
- By:
- Publication type:
- Article
Multicenter Cohort Study to Assess the Association between Changes on Imaging and Outcome after Regorafenib Treatment (KSCC1603).
- Published in:
- Oncology, 2020, v. 98, n. 10, p. 719, doi. 10.1159/000507814
- By:
- Publication type:
- Article
Renal impairment as a risk factor for trifluridine/tipiracil-induced adverse events in metastatic colorectal cancer patients from the REGOTAS study.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-45244-7
- By:
- Publication type:
- Article
Renal impairment as a risk factor for trifluridine/tipiracil-induced adverse events in metastatic colorectal cancer patients from the REGOTAS study.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-45244-7
- By:
- Publication type:
- Article
Schedule-dependent reversion of acquired cisplatin resistance by 5-fluorouracil in a newly established cisplatin-resistant HST-1 human squamous carcinoma cell line.
- Published in:
- International Journal of Cancer, 1996, v. 65, n. 4, p. 479, doi. 10.1002/(SICI)1097-0215(19960208)65:4<479::AID-IJC15>3.0.CO;2-5
- By:
- Publication type:
- Article
Inhibition of cis-diamminedichloroplatinum (II)-induced DNA interstrand cross-link removal by 7-ethyl-10-hydroxy-camptothecin in HST-1 human squamous-carcinoma cells.
- Published in:
- International Journal of Cancer, 1995, v. 62, n. 1, p. 70, doi. 10.1002/ijc.2910620114
- By:
- Publication type:
- Article
Direct tumorigenic conversion of human gallbladder carcinoma cells by v- src but not by activated c-H- ras oncogene.
- Published in:
- International Journal of Cancer, 1995, v. 61, n. 2, p. 206, doi. 10.1002/ijc.2910610211
- By:
- Publication type:
- Article
Multicenter phase II study of FOLFIRI plus bevacizumab after discontinuation of oxaliplatin-based regimen for advanced or recurrent colorectal cancer (CR0802).
- Published in:
- BMC Cancer, 2015, v. 15, n. 1, p. 1, doi. 10.1186/s12885-015-1175-3
- By:
- Publication type:
- Article
Multicenter phase II study of FOLFIRI plus bevacizumab after discontinuation of oxaliplatin-based regimen for advanced or recurrent colorectal cancer (CR0802).
- Published in:
- 2015
- By:
- Publication type:
- journal article
Phase I study of NK105, a nanomicellar paclitaxel formulation, administered on a weekly schedule in patients with solid tumors.
- Published in:
- Investigational New Drugs, 2016, v. 34, n. 6, p. 750, doi. 10.1007/s10637-016-0381-4
- By:
- Publication type:
- Article
A multicenter phase II study of the stop-and-go modified FOLFOX6 with bevacizumab for first-line treatment of patients with metastatic colorectal cancer.
- Published in:
- Investigational New Drugs, 2012, v. 30, n. 5, p. 2026, doi. 10.1007/s10637-011-9779-1
- By:
- Publication type:
- Article
Phase II study of NK105, a paclitaxel-incorporating micellar nanoparticle, for previously treated advanced or recurrent gastric cancer.
- Published in:
- Investigational New Drugs, 2012, v. 30, n. 4, p. 1621, doi. 10.1007/s10637-011-9709-2
- By:
- Publication type:
- Article
A randomized, double-blind, placebo-controlled, Phase III study of pazopanib in patients with soft tissue sarcoma: results from the Japanese subgroup.
- Published in:
- Japanese Journal of Clinical Oncology, 2016, v. 46, n. 3, p. 248, doi. 10.1093/jjco/hyv184
- By:
- Publication type:
- Article
A Phase II Clinical Study of mFOLFOX6 Plus Bevacizumab as First-line Therapy for Japanese Advanced/Recurrent Colorectal Cancer Patients.
- Published in:
- Japanese Journal of Clinical Oncology, 2013, v. 43, n. 11, p. 1080, doi. 10.1093/jjco/hyt127
- By:
- Publication type:
- Article
Burden on Oncologists When Communicating the Discontinuation of Anticancer Treatment.
- Published in:
- Japanese Journal of Clinical Oncology, 2011, v. 41, n. 8, p. 999, doi. 10.1093/jjco/hyr092
- By:
- Publication type:
- Article
A Multicenter Phase-II Study of 5-FU, Leucovorin and Oxaliplatin (FOLFOX6) in Patients with Pretreated Metastatic Colorectal Cancer.
- Published in:
- Japanese Journal of Clinical Oncology, 2011, v. 41, n. 1, p. 63, doi. 10.1093/jjco/hyq158
- By:
- Publication type:
- Article
Phase IIb study of pembrolizumab combined with S‐1 + oxaliplatin or S‐1 + cisplatin as first‐line chemotherapy for gastric cancer.
- Published in:
- Cancer Science, 2022, v. 113, n. 8, p. 2814, doi. 10.1111/cas.15462
- By:
- Publication type:
- Article
FMS‐like tyrosine kinase 3 (FLT3) amplification in patients with metastatic colorectal cancer.
- Published in:
- Cancer Science, 2021, v. 112, n. 1, p. 314, doi. 10.1111/cas.14693
- By:
- Publication type:
- Article
Exploration of potential prognostic biomarkers in aflibercept plus FOLFIRI in Japanese patients with metastatic colorectal cancer.
- Published in:
- Cancer Science, 2019, v. 110, n. 11, p. 3565, doi. 10.1111/cas.14198
- By:
- Publication type:
- Article
Phase I dose‐escalation study of capmatinib (INC280) in Japanese patients with advanced solid tumors.
- Published in:
- Cancer Science, 2019, v. 110, n. 4, p. 1340, doi. 10.1111/cas.13956
- By:
- Publication type:
- Article
Phase II trial of aflibercept with FOLFIRI as a second‐line treatment for Japanese patients with metastatic colorectal cancer.
- Published in:
- Cancer Science, 2019, v. 110, n. 3, p. 1032, doi. 10.1111/cas.13943
- By:
- Publication type:
- Article
Epithelial‐mesenchymal transition is activated in CD44‐positive malignant ascites tumor cells of gastrointestinal cancer.
- Published in:
- Cancer Science, 2018, v. 109, n. 11, p. 3461, doi. 10.1111/cas.13777
- By:
- Publication type:
- Article